NCT07484347 Combined Effects of Sensorimotor Integration and Post-facilitation Stretch in Autism Spectrum Disorder
| NCT ID | NCT07484347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2026-02-20 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2026-02-20 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the effects of sensory motor integration and post facilitation stretch on toe walking and sensory processing behaviors using Foot Posture Index and Sensory Profile respectively.
Eligibility Criteria
Inclusion Criteria: * Children with diagnosed Mild Autism Spectrum Disorder * Presenting with toe walk as a prominent feature of Autism Spectrum Disorder (e.g., more than 50% of steps observed during a gait assessment). Toe walking should be entirely because of Achilles tightness. * Able to follow simple verbal commands. * Sufficient gross motor skills present. Exclusion Criteria: * Toe walking due to neurological (e.g., cerebral palsy, spina bifida, peripheral neuropathy) or orthopedic disorders (e.g., clubfoot, leg length discrepancy \> 1 cm, hip dysplasia, contractures not related to idiopathic toe walking) and other behavioral factors that could be the primary cause of toe walking will be excluded. * History of Achilles tendon surgery or lower limb surgery. * Current participation in another physical therapy intervention targeting gait or posture * Severe behavioral/sensory issues that would interfere with treatment sessions i.e. severe Autism Spectrum Disorder with Attention Deficit Hyperactivity Disorder as well as mental retardation. * Non-ambulatory children.
Contact & Investigator
Maria khalid, MSOMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07484347 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 10 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07484347 currently recruiting?
Yes, NCT07484347 is actively recruiting participants. Contact the research team at maria.khalid@riphah.edu.pk for enrollment information.
Where is the NCT07484347 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07484347 clinical trial?
NCT07484347 is sponsored by Riphah International University. The principal investigator is Maria khalid, MSOMPT at Riphah International University. The trial plans to enroll 36 participants.